BHC Bausch Health Companies Inc

Price (delayed)

$27.76

Market cap

$9.96B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.6

Enterprise value

$31.54B

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of ...

Highlights
BHC's gross profit is up by 6% since the previous quarter and by 3.1% year-on-year
The revenue has increased by 5% since the previous quarter and by 4.6% year-on-year
BHC's EPS is up by 38% year-on-year but it is down by 26% since the previous quarter
The net income has grown by 37% YoY but it has contracted by 26% from the previous quarter
Bausch Health Companies's quick ratio has decreased by 9% from the previous quarter and by 9% YoY

Key stats

What are the main financial stats of BHC
Market
Shares outstanding
358.81M
Market cap
$9.96B
Enterprise value
$31.54B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.18
EV/EBIT
N/A
EV/EBITDA
20.08
EV/Sales
3.72
Earnings
Revenue
$8.48B
EBIT
-$100M
EBITDA
$1.57B
Free cash flow
$1.19B
Per share
EPS
-$3.6
Free cash flow per share
$3.31
Book value per share
-$1.92
Revenue per share
$23.61
TBVPS
$27.54
Balance sheet
Total assets
$30.04B
Total liabilities
$30.65B
Debt
$23.44B
Equity
-$687M
Working capital
-$67M
Liquidity
Debt to equity
-34.12
Current ratio
0.99
Quick ratio
0.63
Net debt/EBITDA
13.74
Margins
EBITDA margin
18.5%
Gross margin
71.4%
Net margin
-15.2%
Operating margin
-0.4%
Efficiency
Return on assets
-4.2%
Return on equity
-2,163%
Return on invested capital
-0.4%
Return on capital employed
-0.4%
Return on sales
-1.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BHC stock price

How has the Bausch Health Companies stock price performed over time
Intraday
-2.7%
1 week
-3.28%
1 month
-3.31%
1 year
56.48%
YTD
33.46%
QTD
-0.32%

Financial performance

How have Bausch Health Companies's revenue and profit performed over time
Revenue
$8.48B
Gross profit
$6.06B
Operating income
-$36M
Net income
-$1.29B
Gross margin
71.4%
Net margin
-15.2%
The company's operating income has shrunk by 117% QoQ but it has surged by 93% YoY
The operating margin has plunged by 115% from the previous quarter but it has soared by 94% YoY
The net margin has increased by 40% year-on-year but it has declined by 20% since the previous quarter
The net income has grown by 37% YoY but it has contracted by 26% from the previous quarter

Growth

What is Bausch Health Companies's growth rate over time

Valuation

What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
N/A
P/S
1.18
EV/EBIT
N/A
EV/EBITDA
20.08
EV/Sales
3.72
BHC's EPS is up by 38% year-on-year but it is down by 26% since the previous quarter
The price to sales (P/S) is 31% higher than the 5-year quarterly average of 0.9 and 7% higher than the last 4 quarters average of 1.1
The revenue has increased by 5% since the previous quarter and by 4.6% year-on-year

Efficiency

How efficient is Bausch Health Companies business performance
BHC's return on invested capital has dropped by 167% since the previous quarter but it has surged by 81% year-on-year
BHC's return on sales has dropped by 163% since the previous quarter but it has surged by 83% year-on-year
The ROA has grown by 33% YoY but it has contracted by 27% from the previous quarter

Dividends

What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BHC.

Financial health

How did Bausch Health Companies financials performed over time
The current ratio has contracted by 12% YoY and by 10% from the previous quarter
Bausch Health Companies's quick ratio has decreased by 9% from the previous quarter and by 9% YoY
The debt to equity has dropped by 166% year-on-year but it has surged by 72% since the previous quarter
The debt has declined by 3.8% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.